股东权益报酬率(%) RoE | |
InMode L | 48.9 |
Fonar Co | 16.0 |
Electrom | 9.3 |
美敦力有限公司 | 8.3 |
Acutus M | 0 |
EDAP TMS | 0 |
Senseoni | 0 |
Cutera, | 0 |
Iridex C | 0 |
LivaNova | 0 |
Conmed C | 0 |
ReShape | 0 |
Heska Co | 0 |
Pacific | 0 |
Koninkli | 0 |
Anika Th | 0 |
Biomeric | 0 |
Cerus Co | 0 |
Glaukos | 0 |
iCAD, In | 0 |
Inspire | 0 |
Motus Gi | 0 |
Novocure | 0 |
Nevro Co | 0 |
Surmodic | 0 |
electroC | 0 |
AdaptHea | 0 |
Butterfl | 0 |
BioSig T | 0 |
Bioventu | 0 |
Cytek Bi | 0 |
现金与约当现金比率(%) | |
CVRx, In | 89.5 |
Movano I | 87.1 |
Motus Gi | 86.7 |
InMode L | 84.8 |
Inspire | 82.5 |
Outset M | 79.4 |
SI-BONE, | 78.7 |
electroC | 77.1 |
Novocure | 76.8 |
Talis Bi | 75.7 |
RxSight, | 73.7 |
Tivic He | 72.7 |
TELA Bio | 72.4 |
Senseoni | 70.8 |
BioSig T | 70.7 |
MaxCyte, | 70.3 |
TransMed | 69.7 |
Inari Me | 66.4 |
Cytek Bi | 65.6 |
Stereota | 64.7 |
Acutus M | 63.3 |
Nuwellis | 62.2 |
Nevro Co | 61.5 |
Butterfl | 57.3 |
Cerus Co | 57.1 |
Pacific | 53.2 |
Treace M | 52.6 |
Axogen, | 50.4 |
EDAP TMS | 49.5 |
Lucid Di | 45.1 |
Cutera, | 44.2 |
营业毛利率(%) | |
MaxCyte, | 89.8 |
SI-BONE, | 88.5 |
Inari Me | 88.0 |
InMode L | 85.2 |
Inspire | 83.6 |
Axogen, | 82.7 |
Paragon | 80.7 |
Treace M | 80.2 |
Electrom | 76.5 |
Glaukos | 76.4 |
Novocure | 75.6 |
CVRx, In | 74.8 |
iCAD, In | 73.6 |
Stereota | 72.5 |
Bioventu | 70.9 |
Nevro Co | 69.0 |
美敦力有限公司 | 68.1 |
BioSig T | 67.5 |
LivaNova | 66.8 |
ZimVie I | 65.7 |
Anika Th | 62.8 |
ReShape | 62.4 |
electroC | 59.9 |
TransMed | 59.5 |
TELA Bio | 57.3 |
Cytek Bi | 57.2 |
Conmed C | 54.7 |
Cutera, | 53.5 |
Cerus Co | 52.8 |
Nuwellis | 49.0 |
Fonar Co | 47.1 |
营业利益率(%) | |
InMode L | 39.1 |
Fonar Co | 20.5 |
美敦力有限公司 | 19.0 |
Electrom | 10.1 |
Conmed C | 7.9 |
AdaptHea | 7.0 |
Cytek Bi | 6.4 |
Koninkli | 5.7 |
Bioventu | 4.0 |
Anika Th | 2.9 |
LivaNova | 1.3 |
Movano I | 0 |
Heska Co | -1.8 |
Surmodic | -1.8 |
EDAP TMS | -1.8 |
ZimVie I | -5.1 |
Paragon | -5.6 |
Novocure | -6.5 |
Cutera, | -8.9 |
Treace M | -12.4 |
Iridex C | -19.2 |
Nevro Co | -20.1 |
Axogen, | -23.2 |
Inari Me | -24.5 |
Glaukos | -27.5 |
Stereota | -30.8 |
Inspire | -32.1 |
iCAD, In | -33.1 |
SI-BONE, | -48.2 |
Biomeric | -48.4 |
MaxCyte, | -53.7 |
纯益率 / 净利率(%) | |
RxSight, | 1367.1 |
InMode L | 35.9 |
Fonar Co | 19.1 |
美敦力有限公司 | 14.0 |
Electrom | 7.6 |
Anika Th | 3.3 |
Koninkli | 2.7 |
Conmed C | 1.5 |
Movano I | 0 |
EDAP TMS | -1.1 |
Cytek Bi | -1.1 |
Heska Co | -2.5 |
AdaptHea | -3.4 |
Surmodic | -4.0 |
Bioventu | -6.2 |
Paragon | -10.1 |
Novocure | -10.4 |
Cutera, | -14.7 |
ZimVie I | -16.1 |
Treace M | -17.3 |
LivaNova | -17.9 |
Iridex C | -18.1 |
Nevro Co | -19.1 |
Glaukos | -21.2 |
Axogen, | -23.4 |
Stereota | -27.2 |
Inari Me | -29.0 |
Inspire | -32.5 |
iCAD, In | -44.0 |
Biomeric | -48.0 |
SI-BONE, | -53.7 |
分红率(%) | |
美敦力有限公司 | 2.52 |
Koninkli | 0.84664 |
Conmed C | 0.8 |
Acutus M | 0 |
electroC | 0 |
EDAP TMS | 0 |
Electrom | 0 |
Fonar Co | 0 |
Iridex C | 0 |
LivaNova | 0 |
Senseoni | 0 |
ReShape | 0 |
Heska Co | 0 |
Pacific | 0 |
Axogen, | 0 |
Anika Th | 0 |
Biomeric | 0 |
Cerus Co | 0 |
Glaukos | 0 |
iCAD, In | 0 |
Inspire | 0 |
Motus Gi | 0 |
Novocure | 0 |
Nevro Co | 0 |
Surmodic | 0 |
Cutera, | 0 |
AdaptHea | 0 |
Butterfl | 0 |
BioSig T | 0 |
Bioventu | 0 |
Cytek Bi | 0 |